Capital News

Stem Cell Service Portfolios at Creative Biolabs Received Critical Upgrades

 Breaking News
  • No posts were found

Stem Cell Service Portfolios at Creative Biolabs Received Critical Upgrades

January 20
17:22 2023
Creative Biolabs, which has been offering stem cell services for decades, is pleased to provide upgraded, high-quality stem cell engineering services to global customers, including genome editing and stem cell drug discovery.

New York, USA – January 20, 2023 – Over the past several years, the investigation of gene and cell therapy has made remarkable progress and acquired many positive experimental results regarding several diseases, such as malignant glioblastoma, leukemia, and other types of cancer. As an industry-leading service provider for stem cells, Creative Biolabs is committed to providing a rich service portfolio to facilitate customers’ stem cell research and/or therapeutic development projects.

Through the continuous pursuit of high customer evaluations, Creative Biolabs preserved its responsibility to provide high-quality stem cell engineering services. The Creative Biolabs Scientific Team has extensive experience in carrying out services for induced pluripotent stem cells (iPSC) from a specific patient clinical profile, as well as custom genome editing.

Meanwhile, Creative Biolabs’ groundbreaking CRISPR/Cas9 platform can deliver reliable engineered CRISPR/Cas9 cell lines that achieve desired gene knockout sequences and facilitate researchers in editing genomes of diverse organisms in a highly efficient manner. Creative Biolabs is honored to introduce its CRISPR/Cas9 services as follows:

* gRNA design and vector construction services

Providing at least 2 gRNAs with ensured vector efficiency offered by Creative Biolabs.

* CRISPR/Cas9 cell line engineering

One-stop CRISPR/Cas9 cell line engineering services include gene synthesis, design of gRNAs, cell transfection, and single clone screening, which are suitable for targets of any genes and mammalian cells.

* Transgenic mouse services

Providing transgenic mice with CRISPR/Cas9-mediated genome modifications.

Furthermore, stem cell technology development represents a promising therapeutic strategy for CNS diseases due to its multi-lineage differentiation potential as well as self-renewal and proliferative abilities. With wide experience accumulated from hundreds of projects in stem cell drug discovery, Creative Biolabs is providing one-stop stem cell drug discovery services as well as employing comprehensive technology platforms and advanced research tools to facilitate stem cell applications for drug discovery.

For more information about stem cell discovery services at Creative Biolabs, please visit

About Creative Biolabs

Creative Biolabs is a full-contract service provider that assists stem cell therapy development. For years, the company has aided hundreds of stem cell development projects, receiving high marks from global partners. Talented experts and technicians, well-allocated resources, and innovative project solutions have set a foundation for Creative Biolabs in accomplishing each project for customers worldwide. Creative Biolabs will continue optimizing its service portfolio while introducing additional innovative solutions to meet customers’ specific demands.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States